Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

11.10
Delayed Data
As of Aug 18
 +0.05 / +0.45%
Today’s Change
8.55
Today|||52-Week Range
11.43
+2.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues40.5M44.1M42.9M44.5M
 
 
 
 
 
Cost of Goods Sold5.6M5.5M5.9M5.4M
 
 
 
 
 
Depreciation And Amortization--248.0K246.0K268.0K
 
 
 
 
 
Operating ExpensesGross Income35.0M38.3M36.7M38.9M
 
 
 
 
 
General Expenses24.5M30.9M22.5M27.2M
 
 
 
 
 
Research And Development3.3M5.6M2.5M2.8M
 
 
 
 
 
Total Operating Expenses30.1M36.7M28.7M32.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income10.5M7.4M14.2M11.6M
 
 
 
 
 
Other Expenses451.0K-494.0K1.1M867.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income11.2M7.2M15.6M12.8M
 
 
 
 
 
Income Taxes-1.1M-772.0K-1.0M-589.0K
 
 
 
 
 
Net Income10.1M6.4M14.6M12.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.4M51.1M51.4M51.8M
 
 
 
 
 
Shares To Calculate EPS Diluted52.6M52.8M53.0M53.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.19$0.12$0.28$0.23
 
 
 
 
 
EPS Diluted$0.19$0.12$0.28$0.23